|
| Introduction of the VHPB |
| , Pierre Van Damme |
| Nov/2009 - Istanbul, Turkey | | 646 Kb (.pdf) |
|
| Molecular epidemiology of viral hepatitis in Turkey |
| Hakan Abacioglu |
| Nov/2009 - Istanbul, Turkey | | 3,745 Kb (.pdf) |
|
| Mutants problems in Turkey |
| Ulus Akarca |
| Nov/2009 - Istanbul, Turkey | | 1,004 Kb (.pdf) |
|
| Economic aspects of viral hepatitis in Turkey |
| Levent Akin |
| Nov/2009 - Istanbul, Turkey | | 874 Kb (.pdf) |
|
| Therapeutic algorithm in the treatment of chronic hepatitis in Turkey |
| Yilmaz Cakaloglu |
| Nov/2009 - Istanbul, Turkey | | 485 Kb (.pdf) |
|
| The hepatitis A vaccination in Turkey: targeted versus universal |
| Mehmet Ceyhan |
| Nov/2009 - Istanbul, Turkey | | 1,169 Kb (.pdf) |
|
| Victimes of human trafficking and viral hepatitis |
| Muhtar Cokar |
| Nov/2009 - Kyiv, Ukraine | | 888 Kb (.pdf) |
|
| Healthcare workers and viral hepatitis |
| Bulent Degertekin |
| Nov/2009 - Istanbul, Turkey | | 478 Kb (.pdf) |
|
| HBV prevention and control programmes in Turkey and in the European Region of WHO |
| Nedret Emiroglu |
| Nov/2009 - Istanbul, Turkey | | 671 Kb (.pdf) |
|
| The epidemiological situation of hepatitis C in Turkey |
| Selda Erensoy |
| Nov/2009 - Istanbul, Turkey | | 1,123 Kb (.pdf) |
|
| Conclusions VHPB Turkey meeting 2009 |
| David FitzSimons |
| Nov/2009 - Istanbul, Turkey | | 87 Kb (.pdf) |
|
| Results from the blood bank screening in Turkey |
| Yasemin Heper |
| Nov/2009 - Istanbul, Turkey | | 284 Kb (.pdf) |
|
| Viral hepatitis and Transplantation. |
| Zeki Karasu |
| Nov/2009 - Istanbul, Turkey | | 1,796 Kb (.pdf) |
|
| Global HCV prevention and control measures: lesson learnt and opportunities |
| Daniel Lavanchy |
| Nov/2009 - Istanbul, Turkey | | 403 Kb (.pdf) |
|
| Speeding-up Hepatitis B and C control in WHO Eastern Mediterranean Region |
| Ezzedine Mohsni |
| Nov/2009 - Istanbul, Turkey | | 2,933 Kb (.pdf) |
|
| HBV immunization policies and lessons learnt after 10 years of implementation |
| Umit Ozdemirer |
| Nov/2009 - Istanbul, Turkey | | 2,456 Kb (.pdf) |
|
| Communicable diseases surveillance systems and immunization service delivery |
| Umit Ozedemirer |
| Nov/2009 - Istanbul, Turkey | | 881 Kb (.pdf) |
|
| The epidemiological situation of hepatitis B and D in Turkey |
| Arzu Sayiner |
| Nov/2009 - Istanbul, Turkey | | 706 Kb (.pdf) |
|
| Approach of NGO's |
| Nurdan Tozun |
| Nov/2009 - Istanbul, Turkey | | 934 Kb (.pdf) |
|
| Epidemiology of chronic hepatitis and cirrhosis in Turkey |
| Cihan Yurdaydin |
| Nov/2009 - Istanbul, Turkey | | 2,114 Kb (.pdf) |
|
| Increase in Hepatitis A cases in the Czech Republic in 2008 |
| J Cástková |
| Mar/2009 - Antwerp, Belgium | | 270 Kb (.pdf) |
|
| Autochthonous hepatitis E in Southwest England. |
| Harry R Dalton |
| Mar/2009 - Antwerp, Belgium | | 460 Kb (.pdf) |
|
| Non-travel related Hepatitis E virus infections in the Netherlands. |
| Erwin Duizer |
| Mar/2009 - Antwerp, Belgium | | 471 Kb (.pdf) |
|
| Presentation of the VHPB meeting conclusions. |
| David FitzSimons |
| Mar/2009 - Antwerp, Belgium | | 128 Kb (.pdf) |
|
| Distribution of hepatitis E virus in the environment. |
| Rosina Girones |
| Mar/2009 - Antwerp, Belgium | | 988 Kb (.pdf) |
|
| Prevalence of hepatitis E virus infection in children in Northeast of Spain. |
| Rosina Girones |
| Mar/2009 - | | 137 Kb (.pdf) |
|
| Hepatitis E in Asian Region. |
| Emily Gurley |
| Mar/2009 - Antwerp, Belgium | | 3,871 Kb (.pdf) |
|
| Safety and efficacy of a recombinant hepatitis E vaccine. |
| Bruce Innis |
| Mar/2009 - Antwerp, Belgium | | 194 Kb (.pdf) |
|
| Hepatitis E Virus Infection in Germany |
| Wolfgang Jilg |
| Mar/2009 - Antwerp, Belgium | | 173 Kb (.pdf) |
|
| Hepatitis E virus and chronic hepatitis in organ-transplant recipients. |
| Nassim Kamar |
| Mar/2009 - Antwerp, Belgium | | 1,447 Kb (.pdf) |
|
| Pathogenesis and natural history of hepatitis E. |
| Krzysztof Krawczynski |
| Mar/2009 - Antwerp, Belgium | | 1,119 Kb (.pdf) |
|
| Acute hepatitis E in south-west France over a 5-year period |
| Jean Michel Mansuy |
| Mar/2009 - Antwerp, Belgium | | 655 Kb (.pdf) |
|
| Update on Hepatitis A epidemiology and prevention in WHO European Region |
| David Mercer |
| Mar/2009 - Antwerp, Belgium | | 132 Kb (.pdf) |
|
| The seroprevalence of HEV in the National Health and Nutrition Sample of the United States population. |
| Kenrad Nelson |
| Mar/2009 - Antwerp, Belgium | | 646 Kb (.pdf) |
|
| EVENT, a network for harmonization typing of HAV and for alerting on hepatitis A outbreaks. |
| Helene Norder |
| Mar/2009 - Antwerp, Belgium | | 110 Kb (.pdf) |
|
| Molecular epidemiology of hepatitis E, taxonomy, molecular biology,genotypes and subtypes |
| Helene Norder |
| Mar/2009 - Antwerp, Belgium | | 299 Kb (.pdf) |
|
| Hepatitis E: a curious zoönosis |
| Nicole Pavio |
| Mar/2009 - Antwerp, Belgium | | 753 Kb (.pdf) |
|
| Community-wide outbreak of Hepatitis A in Latvia |
| J Perevoscikovs |
| Mar/2009 - Antwerp, Belgium | | 2,799 Kb (.pdf) |
|
| Hepatitis E from A to Z: Discovery and Characterization |
| Robert Purcell |
| Mar/2009 - Antwerp, Belgium | | 2,878 Kb (.pdf) |
|
| Global overview on the effectiveness of Hepatitis A vaccination programs |
| Umid Sharapov |
| Mar/2009 - Antwerp, Belgium | | 622 Kb (.pdf) |
|
| Randomized-controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. |
| James Wai-kuo Shih |
| Mar/2009 - Antwerp, Belgium | | 1,029 Kb (.pdf) |
|
| What are the risk factors with an impact on fatality rate in fulminant hepatitis A? |
| Daniel Shouval |
| Mar/2009 - Antwerp, Belgium | | 536 Kb (.pdf) |
|
| Hepatitis E vaccine: Clinical experience |
| Mrigendra Shrestha |
| Mar/2009 - Antwerp, Belgium | | 716 Kb (.pdf) |
|
| Long-term immunity induced by hepatitis A vaccines: an update |
| Koen Van Herck |
| Mar/2009 - Antwerp, Belgium | | 263 Kb (.pdf) |
|
| Summary of major findings and conclusions of Global Hepatitis A meeting, Miami dec. 2007 |
| Pierre Van Damme |
| Mar/2009 - Antwerp, Belgium | | 562 Kb (.pdf) |
|
| Introduction of the VHPB |
| Pierre Van Damme |
| Mar/2009 - Antwerp, Belgium | | 1,117 Kb (.pdf) |
|
| Correlation between humoral and cellular immune responses and the expression of the hepatitis A receptor HAVcr-1 on T cells after Hepatitis A vaccination in high and low responder. |
| Ursula Wiedermann |
| Mar/2009 - Antwerp, Belgium | | 771 Kb (.pdf) |
|
| Review of the Hepatitis A WHO position paper: need for an update? |
| Steven Wiersma |
| Mar/2009 - Antwerp, Belgium | | 196 Kb (.pdf) |
|
| Hepatitis E in Italy |
| Alessandro Zanetti |
| Mar/2009 - Antwerp, Belgium | | 360 Kb (.pdf) |
|
| Pregnancy and viral hepatitis. |
| Greet Boland |
| Nov/2008 - Rotterdam, The Netherlands | | 338 Kb (.pdf) |
|
| Molecular epidemiology of HBV infection in The Netherlands. |
| Hein Boot |
| Nov/2008 - Rotterdam, The Netherlands | | 375 Kb (.pdf) |
|
| Approach to the different risk groups for HBV and/or HCV. |
| Robert de Knegt |
| Nov/2008 - Rotterdam, The Netherlands | | 477 Kb (.pdf) |
|
| Update on prevention and control of hepatitis B in WHO European Region. |
| Nedret Emiroglu |
| Nov/2008 - Rotterdam, The Netherlands | | 509 Kb (.pdf) |
|
| Presentation of the VHPB meeting conclusions |
| David FitzSimons |
| Nov/2008 - Rotterdam, The Netherlands | | 142 Kb (.pdf) |
|
| Overview of HAV, HBV, HCV surveillance in The Netherlands |
| Susan Hahné |
| Nov/2008 - Rotterdam, The Netherlands | | 389 Kb (.pdf) |
|
| Hepatitis B vaccination in The Netherlands: Risk group approach. |
| Susan Hahné |
| Nov/2008 - Rotterdam, The Netherlands | | 450 Kb (.pdf) |
|
| National immunisation program and viral hepatitis immunisation policies. |
| Hans Houweling |
| Nov/2008 - Rotterdam, The Netherlands | | 1,000 Kb (.pdf) |
|
| Need for chronic viral hepatitis monitoring system. |
| Harry Janssen |
| Nov/2008 - Rotterdam, The Netherlands | | 1,057 Kb (.pdf) |
|
| Epidemiology of hepatitis B infection in The Netherlands. |
| Myriam Kretzschmar |
| Nov/2008 - Kyiv, Ukraine | | 847 Kb (.pdf) |
|
| National program and epidemiology of hepatitis C in the Netherlands. |
| Henk Reesink |
| Nov/2008 - Edinburgh, United Kingdom | | 279 Kb (.pdf) |
|
| Hepatitis B vaccination in The Netherlands: Universal approach |
| Clemence Richter |
| Nov/2008 - Rotterdam, The Netherlands | | 474 Kb (.pdf) |
|
| Mortality from viral hepatitis in The Netherlands |
| Solko Schalm |
| Nov/2008 - Rotterdam, The Netherlands | | 382 Kb (.pdf) |
|
| Epidemiology of Hepatitis C infections in The Netherlands. |
| Serena Slavenburg |
| Nov/2008 - Rotterdam, The Netherlands | | 383 Kb (.pdf) |
|
| Molecular epidemiology of HCV infection in The Netherlands |
| Thijs van de Laar |
| Nov/2008 - Rotterdam, The Netherlands | | 530 Kb (.pdf) |
|
| Limited control of Hepatitis A by decentralized vaccination strategies |
| Jim van Steenbergen |
| Nov/2008 - Rotterdam, The Netherlands | | 234 Kb (.pdf) |
|
| Epidemiology of hepatitis A and E in The Netherlands. |
| Jim van Steenbergen |
| Nov/2008 - Rotterdam, The Netherlands | | 1,018 Kb (.pdf) |
|
| Introduction of the VHPB. |
| Pierre Van Damme |
| Nov/2008 - Rotterdam, The Netherlands | | 1,055 Kb (.pdf) |
|
| Screening of migrants. |
| Irene Veldhuijzen |
| Nov/2008 - Rotterdam, The Netherlands | | 399 Kb (.pdf) |
|
| Migration and viral hepatitis. |
| Tania Wörmann |
| Nov/2008 - Rotterdam, The Netherlands | | 686 Kb (.pdf) |
|
| Health care-associated viral hepatitis. |
| Hans Zaaijer |
| Nov/2008 - Rotterdam, The Netherlands | | 275 Kb (.pdf) |
|
| Belgium: Carrefour Hépatites-Aide et Contact // Vereniging voor hepatitis C patienten. |
| Muriel Colinet, Marie-Fabienne Van den Berghe |
| Mar/2008 - Lucca, Italy | | 945 Kb (.pdf) |
|
| Presentation of the VHPB meeting conclusions. |
| David FitzSimons |
| Mar/2008 - Lucca, Italy | | 75 Kb (.pdf) |
|
| Italy: EpaC |
| Ivan Gardini |
| Mar/2008 - Lucca, Italy | | 634 Kb (.pdf) |
|
| World Hepatitis Day (WHD). |
| Charles Gore |
| Mar/2008 - Lucca, Italy | | 56 Kb (.pdf) |
|
| Hepatitis B priority area for European policy; Call for action by the European Parliament. |
| Charles Gore |
| Mar/2008 - Lucca, Italy | | 81 Kb (.pdf) |
|
| Bulgaria: Hepasist. |
| Stanimir Hasurdjiev |
| Mar/2008 - Lucca, Italy | | 5,984 Kb (.pdf) |
|
| Relationship between industry and patient organisations: European Federation of Pharmaceutical industries and associations (EFPIA) ethical code. |
| Luc Hessel |
| Mar/2008 - Lucca, Italy | | 511 Kb (.pdf) |
|
| Germany: Deutsche Leberhilfe. |
| Achim Kautz |
| Mar/2008 - Lucca, Italy | | 54 Kb (.pdf) |
|
| US: The Hepatitis Foundation International. |
| Thelma King Thiel |
| Mar/2008 - Lucca, Italy | | 61 Kb (.pdf) |
|
| European patient groups for rare diseases. |
| Michele Lipucci di Paola |
| Mar/2008 - Lucca, Italy | | 810 Kb (.pdf) |
|
| UK: British Liver Trust . |
| Sarah Matthews |
| Mar/2008 - Lucca, Italy | | 470 Kb (.pdf) |
|
| The European Immunization Week |
| Liudmila Mosina |
| Mar/2008 - Lucca, Italy | | 856 Kb (.pdf) |
|
| Update on prevention and control of hepatitis B in WHO European Region. |
| Liudmila Mosina |
| Mar/2008 - Lucca, Italy | | 1,022 Kb (.pdf) |
|
| Prevention and control of viral hepatitis; the role and impact of liver patient groups in Europe: general considerations. |
| Nadine Piorkowsky |
| Mar/2008 - Lucca, Italy | | 308 Kb (.pdf) |
|
| Croatia: Hepatos. |
| Tatjana Reic |
| Mar/2008 - Lucca, Italy | | 356 Kb (.pdf) |
|
| Poland: Prometeuze. |
| Ilona Sikorska |
| Mar/2008 - Lucca, Italy | | 75 Kb (.pdf) |
|
| Advocating for immigrant communities at risk. |
| Samuel So |
| Mar/2008 - Lucca, Italy | | 1,261 Kb (.pdf) |
|
| The Netherlands : National Hepatitis Centre. |
| Paula Van Leeuwen |
| Mar/2008 - Lucca, Italy | | 77 Kb (.pdf) |
|
| Introduction of the VHPB |
| Pierre Van Damme |
| Mar/2008 - Lucca, Italy | | 423 Kb (.pdf) |
|
| Prevention and control of viral hepatitis in the US; the National Viral Hepatitis Roundtable. |
| Deborah L. Wexler |
| Mar/2008 - Lucca, Italy | | 1,374 Kb (.pdf) |
|
| Viral hepatitis coinfection in HIV-infected patients |
| Ioannis Baraboutis |
| Nov/2007 - Athens, Greece | | 1,169 Kb (.pdf) |
|
| Cohort of HBV and HCV patients |
| Emanuel Manesis |
| Nov/2007 - Athens, Greece | | 448 Kb (.pdf) |
|
| EUVAC.NET's activities: Expectations and results |
| Mark Muscat |
| Nov/2007 - Athens, Greece | | 1,222 Kb (.pdf) |
|
| Viral hepatitis A, B and C surveillance in Greece |
| Georgia Nikolopoulo |
| Nov/2007 - Athens, Greece | | 316 Kb (.pdf) |
|
| Hepatitis B and hepatitis A vaccination uptake in the child population of Greece |
| Takis Panagiotopoulos |
| Nov/2007 - Athens, Greece | | 196 Kb (.pdf) |
|
| Epidemiology of hepatitis B and D in Greece |
| George Papaetheodoridis |
| Nov/2007 - Athens, Greece | | 355 Kb (.pdf) |
|
| The hepatitis A vaccination program in Greece: Targeted versus universal immunization |
| Vassiliki Papaevangelou |
| Nov/2007 - Athens, Greece | | 449 Kb (.pdf) |
|
| Hepatitis B immunization policies |
| Vassiliki Papaevangelou |
| Nov/2007 - Athens, Greece | | 198 Kb (.pdf) |
|
| Epidemiology of hepatitis A and E in Greece |
| Vassiliki Papaevangelou |
| Nov/2007 - Athens, Greece | | 281 Kb (.pdf) |
|
| Molecular epidemiology of HBV and HCV in Greece |
| Dimitros Paraskevis |
| Nov/2007 - Athens, Greece | | 3,027 Kb (.pdf) |
|
| Universal vaccination against hepatitis A: Lessons from the experience in Immunization of toddlers in Israel |
| Daniel Shouval |
| Nov/2007 - Athens, Greece | | 316 Kb (.pdf) |
|
| National seroprevalence study: Discussion of different approaches. |
| Giota Touloumi |
| Nov/2007 - Athens, Greece | | 235 Kb (.pdf) |
|
| Organization of the health care system and financement in Greece |
| Yannis Tountas |
| Nov/2007 - Athens, Greece | | 275 Kb (.pdf) |
|
| Experience gained from surveillance of infectious diseases during the Olympics. How can we extend it to real life? |
| Sotirios Tsiodras |
| Nov/2007 - Athens, Greece | | 951 Kb (.pdf) |
|
| Introduction of the Viral Hepatitis Prevention Board (VHPB). |
| Pierre Van Damme |
| Nov/2007 - Athens, Greece | | 366 Kb (.pdf) |
|
| Prevention and control of viral hepatitis virus in Greece: Lessons learnt and the way forward |
| Pierre Van Damme |
| Nov/2007 - Athens, Greece | | 181 Kb (.pdf) |
|
| Surveillance in blood bank in Greece |
| Agoritsa Varaklioti |
| Nov/2007 - Athens, Greece | | 240 Kb (.pdf) |
|
| Migration and viral hepatitis |
| Vasiliki Vasilopoulou |
| Nov/2007 - Athens, Greece | | 205 Kb (.pdf) |
|
| Introduction of the Hellenic Centre for Infectious Disease Control (KEEL) |
| Anastasia Zisouli |
| Nov/2007 - Athens, Greece | | 29 Kb (.pdf) |
|
| National program for viral hepatitis prevention and control |
| Anastasia Zisouli |
| Nov/2007 - Athens, Greece | | 247 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Turkey. |
| Selim Badur |
| Mar/2007 - Ljubljana, Slovenia | | 63 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Italy. |
| Paolo Bonanni |
| Mar/2007 - Ljubljana, Slovenia | | 94 Kb (.pdf) |
|
| Gaps in knowledge on adolescent health. |
| Ueli Bühlmann |
| Mar/2007 - Ljubljana, Slovenia | | 555 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in The Netherlands. |
| Rudy Burgmeijer |
| Mar/2007 - Ljubljana, Slovenia | | 655 Kb (.pdf) |
|
| Vaccination at school - future challenges |
| Claire Cameron |
| Mar/2007 - Ljubljana, Slovenia | | 316 Kb (.pdf) |
|
| Prevention and control of viral hepatitis through adolescent health programmes in Europe: Conclusions and summary of the meeting. |
| David FitzSimons |
| Mar/2007 - Ljubljana, Slovenia | | 67 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in the UK. |
| Roger Harrington |
| Mar/2007 - Ljubljana, Slovenia | | 178 Kb (.pdf) |
|
| Adolescent and vaccination: Knowledge and perception. |
| Luc Hessel |
| Mar/2007 - Ljubljana, Slovenia | | 864 Kb (.pdf) |
|
| Introduction of European Union for School and Univeristy Health and Medicine (EUSUHM). |
| Karel Hoppenbrouwers |
| Mar/2007 - Ljubljana, Slovenia | | 63 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Belgium |
| Karel Hoppenbrouwers |
| Mar/2007 - Ljubljana, Slovenia | | 90 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Finland. |
| Kaarina Jävenpää |
| Mar/2007 - Ljubljana, Slovenia | | 167 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Slovenia. |
| Mojca Juricic |
| Mar/2007 - Ljubljana, Slovenia | | 239 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Rep of Macedonia. |
| Mimi Karovska |
| Mar/2007 - Ljubljana, Slovenia | | 602 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Croatia. |
| Marina Kuzman |
| Mar/2007 - Ljubljana, Slovenia | | 386 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Norway. |
| Hanne Nokleby |
| Mar/2007 - Ljubljana, Slovenia | | 67 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Greece. |
| Vassiliki Papaevangelou |
| Mar/2007 - Ljubljana, Slovenia | | 55 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Germany |
| Matthias Pulz |
| Mar/2007 - Ljubljana, Slovenia | | 214 Kb (.pdf) |
|
| Issues in implementing hepatitis B vaccination in adolescents. |
| Susan Rosenthal |
| Mar/2007 - Ljubljana, Slovenia | | 309 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in France. |
| Francoise Roudot-Thoraval, Nicole Guérin |
| Mar/2007 - Ljubljana, Slovenia | | 87 Kb (.pdf) |
|
| WHO and Adolescent Immunization |
| Craig Shapiro |
| Mar/2007 - Ljubljana, Slovenia | | 461 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Hungary. |
| Tamas Simon |
| Mar/2007 - Ljubljana, Slovenia | | 60 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in Switzerland. |
| Susanne Stronski |
| Mar/2007 - Ljubljana, Slovenia | | 445 Kb (.pdf) |
|
| Introduction of the Viral Hepatitis Prevention Board (VHPB). |
| Pierre Van Damme |
| Mar/2007 - Ljubljana, Slovenia | | 200 Kb (.pdf) |
|
| Adolescent health programme and its contribution to the success of vaccination in the US. |
| John Ward |
| Mar/2007 - Ljubljana, Slovenia | | 506 Kb (.pdf) |
|
| Hepatitis B Virus Genetic diversity in Spain. |
| Ana Avellon |
| Nov/2006 - Madrid, Spain | | 1,659 Kb (.pdf) |
|
| Epidemiology of Hepatitis C Infection |
| Pablo Barreiro |
| Nov/2006 - Madrid, Spain | | 1,118 Kb (.pdf) |
|
| Epidemiological Surveillance of HCV Infection in Spanish Dialysis Units |
| Guillermina Barril |
| Nov/2006 - Madrid, Spain | | 1,869 Kb (.pdf) |
|
| Molecular diagnosis of hepatitis B infection in the transfusional setting |
| Emma Castro |
| Nov/2006 - Madrid, Spain | | 183 Kb (.pdf) |
|
| Prevalence of HCV-HIV co-infection among mothers of newborn babies |
| Mercedes Diez |
| Nov/2006 - Madrid, Spain | | 324 Kb (.pdf) |
|
| Vaccination against hepatitis A in Catalonia |
| Angela Dominguez |
| Nov/2006 - Madrid, Spain | | 177 Kb (.pdf) |
|
| Molecular Epidemiology of Hepatitis A and E viruses |
| Rosina Girones |
| Nov/2006 - Madrid, Spain | | 732 Kb (.pdf) |
|
| Outbreaks of hepatitis A in Spain |
| Dionisio José Herrera Guibert |
| Nov/2006 - Madrid, Spain | | 851 Kb (.pdf) |
|
| Hepatits E virus infections in Spain |
| Maria Teresa Perez Gracia |
| Nov/2006 - Madrid, Spain | | 2,086 Kb (.pdf) |
|
| Molecular epidemiology of HCV |
| Josep Quer |
| Nov/2006 - Madrid, Spain | | 1,012 Kb (.pdf) |
|
| Treatment of chronic hepatitis B |
| José M Sanchez Tapias |
| Nov/2006 - Madrid, Spain | | 126 Kb (.pdf) |
|
| Treatment of chronic hepatitis C |
| José M Sanchez Tapias |
| Nov/2006 - Madrid, Spain | | 169 Kb (.pdf) |
|
| Organization of the health care system in Spain |
| Patricia Santa Olalla Peralta |
| Nov/2006 - Madrid, Spain | | 390 Kb (.pdf) |
|
| Hepatitis vaccination policy in Spain |
| Patricia Santa Olalla Peralta |
| Nov/2006 - Madrid, Spain | | 190 Kb (.pdf) |
|
| Prevention and control of viral hepatitis virus in Spain: Lessons learnt and the way forward. Conclusions |
| Daniel Shouval |
| Nov/2006 - Madrid, Spain | | 32 Kb (.pdf) |
|
| National Epidemiological Surveillance Network: Hepatitis |
| Carmen Varela Martinez |
| Nov/2006 - Madrid, Spain | | 1,035 Kb (.pdf) |
|
| Effectiveness of newborn hepatitis B vaccination programmes |
| Francis André |
| Mar/2006 - Istanbul, Turkey | | 1,097 Kb (.pdf) |
|
| Are immunogenicity and protective efficacy of hepatitis B vaccine related to different administration schedules? |
| Voranush Chongsrisawat |
| Mar/2006 - Istanbul, Turkey | | 625 Kb (.pdf) |
|
| Overview of HBV Infections and the vaccination policy in Turkey |
| Meral Ciblak, Selim Badur |
| Mar/2006 - Istanbul, Turkey | | 532 Kb (.pdf) |
|
| Prevention and control of perinatal hepatitis B virus transmission in the WHO European Region Introduction |
| Nedret Emiroglu |
| Mar/2006 - Istanbul, Turkey | | 85 Kb (.pdf) |
|
| Prevention of perinatal HBV transmission: Evaluation of programs and success stories from Central Asia and Kazakhstan |
| Michael Favorov |
| Mar/2006 - Istanbul, Turkey | | 1,825 Kb (.pdf) |
|
| Prevention and control of perinatal hepatitis B virus (HBV) transmission in the WHO European Region: Conclusions and summary of the meeting |
| David FitzSimons |
| Mar/2006 - Istanbul, Turkey | | 121 Kb (.pdf) |
|
| Prevention and control of HBV perinatal transmission in Armenia |
| Armen Hayrapetyan |
| Mar/2006 - Istanbul, Turkey | | 967 Kb (.pdf) |
|
| Long term efficacy of hepatitis B vaccination of newborns from HBs Ag positive mothers in Thailand |
| Bernard Hoet |
| Mar/2006 - Istanbul, Turkey | | 58 Kb (.pdf) |
|
| Prevention and control of perinatal transmission of hepatitis B virus: Situation and experience in Georgia |
| Paata Imnadze |
| Mar/2006 - Istanbul, Turkey | | 656 Kb (.pdf) |
|
| Prevention and control of perinatal hepatitis B virus: situation and experience in Tajikistan |
| Shamsiddin Jabirov |
| Mar/2006 - Istanbul, Turkey | | 873 Kb (.pdf) |
|
| Prevention and control of perinatal hepatitis B virus transmission in the Republic of Kyrgyzstan |
| Joldosh Kalilov |
| Mar/2006 - Istanbul, Turkey | | 264 Kb (.pdf) |
|
| The main modes of HBV transmission in children, Central Asian Region |
| Liudmila Mosina |
| Mar/2006 - Istanbul, Turkey | | 1,658 Kb (.pdf) |
|
| Prevention and control of perinatal transmission of viral hepatitis B: Uzbekistan experience |
| Irkin Musabaev |
| Mar/2006 - Istanbul, Turkey | | 1,943 Kb (.pdf) |
|
| Improving the hepatitis B birth dose in Indonesia, Vietnam, and Cambodia |
| Carib Nelson |
| Mar/2006 - Istanbul, Turkey | | 1,015 Kb (.pdf) |
|
| Hepatitis B vaccination and HBIg administration policies implemented for premature babies - vaccines concurrently administrated with the hepatitis B vaccine birth dose |
| Vassiliki Papaevangelou |
| Mar/2006 - Istanbul, Turkey | | 530 Kb (.pdf) |
|
| Hepatitis B vaccination of newborns in rural China: evaluation of an out-of-cold-chain delivery strategy |
| Lixia Wang |
| Mar/2006 - Istanbul, Turkey | | 590 Kb (.pdf) |
|
| Hepatitis B disease burden: a model for global estimates and impact of vaccination |
| Susan Wang |
| Mar/2006 - Istanbul, Turkey | | 131 Kb (.pdf) |
|
| WHO recommendations and guidelines for the prevention of perinatal hepatitis B and use of hepatitis B vaccines |
| Steven Wiersma |
| Mar/2006 - Istanbul, Turkey | | 288 Kb (.pdf) |
|
| Hepatitis B: public health aspects - Glasgow |
| Syed Ahmed |
| Nov/2005 - Edinburgh, United Kingdom | | 207 Kb (.pdf) |
|
| Virology of hepatitis B |
| William Carman |
| Nov/2005 - Edinburgh, United Kingdom | | 1,150 Kb (.pdf) |
|
| Epidemiology and control of hepatitis A in the UK |
| Natasha Crowcroft |
| Nov/2005 - Edinburgh, United Kingdom | | 329 Kb (.pdf) |
|
| National hepatitis C strategy/ Action plans/ SIGN guidelines |
| John Dillon |
| Nov/2005 - Edinburgh, United Kingdom | | 492 Kb (.pdf) |
|
| Clinical aspects |
| Geoffrey Dusheiko |
| Nov/2005 - Edinburgh, United Kingdom | | 324 Kb (.pdf) |
|
| Hepatitis B: economic aspects |
| W. John Edmunds |
| Nov/2005 - Edinburgh, United Kingdom | | 211 Kb (.pdf) |
|
| Can the United Kingdom control viral hepatitis? Preliminary meeting conclusions. |
| Guido François |
| Nov/2005 - Edinburgh, United Kingdom | | 49 Kb (.pdf) |
|
| Hepatitis C: economic issues |
| Richard Grieve |
| Nov/2005 - Edinburgh, United Kingdom | | 85 Kb (.pdf) |
|
| Modelling transmission of HCV among intravenous drug users and in prisons |
| Matthew Hickman |
| Nov/2005 - Edinburgh, United Kingdom | | 173 Kb (.pdf) |
|
| Hepatitis C virus infection: monitoring of end-stage liver disease and modelling the current and future burden of disease |
| Sharon Hutchinson |
| Nov/2005 - Edinburgh, United Kingdom | | 563 Kb (.pdf) |
|
| Hepatitis B in London public health aspects |
| Helen Maguire |
| Nov/2005 - Edinburgh, United Kingdom | | 1,073 Kb (.pdf) |
|
| Epidemiology of hepatitis B in the UK |
| Mary Ramsay |
| Nov/2005 - Edinburgh, United Kingdom | | 680 Kb (.pdf) |
|
| Epidemiology of hepatitis C in the UK |
| Kristy Roy |
| Nov/2005 - Edinburgh, United Kingdom | | 555 Kb (.pdf) |
|
| The cost effectiveness of case-finding strategies for HCV infection in former injecting drug users |
| Ken Stein |
| Nov/2005 - Edinburgh, United Kingdom | | 147 Kb (.pdf) |
|
| How England, Wales, Scotland, and Northern Ireland fit together - politics, healthcare, decision making, research, funding |
| Howard Thomas |
| Nov/2005 - Edinburgh, United Kingdom | | 129 Kb (.pdf) |
|
| Management of diagnosed cases of hepatitis C virus infection |
| Mark Thursz |
| Nov/2005 - Edinburgh, United Kingdom | | 533 Kb (.pdf) |
|
| Transmission of blood-borne viruses in the healthcare setting |
| Gabriella De Carli |
| Mar/2005 - Rome, Italy | | 589 Kb (.pdf) |
|
| Current vaccination policies for healthcare workers, including booster policies, vaccination coverage, and serological testing |
| Antoon De Schryver |
| Mar/2005 - Rome, Italy | | 290 Kb (.pdf) |
|
| Prevalence of HBV and HCV in health care workers |
| Annarosa Floreani |
| Mar/2005 - Rome, Italy | | 1,072 Kb (.pdf) |
|
| Should patients be tested before undergoing invasive procedures? |
| Johannes Hallauer |
| Mar/2005 - Rome, Italy | | 138 Kb (.pdf) |
|
| General precautionary measures |
| Andreas Kopka |
| Mar/2005 - Rome, Italy | | 1,590 Kb (.pdf) |
|
| Post-exposure management of occupational exposure to blood-borne pathogens |
| Fortune Ncube |
| Mar/2005 - Rome, Italy | | 494 Kb (.pdf) |
|
| Risk assessement of occupational and nosocomial HBV/HCV infection by type of clinician and procedure |
| Lidia Proietti |
| Mar/2005 - Rome, Italy | | 705 Kb (.pdf) |
|
| Occupational fraction of HBV and HCV infections in healthcare workers globally |
| Annette Pruss-Ustun |
| Mar/2005 - Rome, Italy | | 575 Kb (.pdf) |
|
| Definitions: exposure-prone procedures, nosocomial infection, viral-load thresholds for HBV, HCV, and HIV infectivity |
| Vincenzo Puro |
| Mar/2005 - Rome, Italy | | 1,221 Kb (.pdf) |
|
| Look-back (retrospective) studies |
| Vincenzo Puro |
| Mar/2005 - Rome, Italy | | 367 Kb (.pdf) |
|
| Inventory of current recommendations |
| Kristy Roy |
| Mar/2005 - Rome, Italy | | 469 Kb (.pdf) |
|
| Feedback from the EASL study (Gunson et al., 2003) |
| Daniel Shouval |
| Mar/2005 - Rome, Italy | | 397 Kb (.pdf) |
|
| Quantitative HBV DNA measurements and the management of infected healthcare workers |
| Annemiek van der Eijk |
| Mar/2005 - Rome, Italy | | 782 Kb (.pdf) |
|
| Healthcare-related outbreaks of hepatitis B and C in the United States |
| Ian Williams |
| Mar/2005 - Rome, Italy | | 468 Kb (.pdf) |
|
| Co-infected healthcare workers |
| Yazdan Yazdanpanah |
| Mar/2005 - Rome, Italy | | 538 Kb (.pdf) |
|
| Nosocomial HCV infections in France |
| Anne Carbonne |
| Nov/2004 - Veyrier-du-Lac, France | | 184 Kb (.pdf) |
|
| Overview of HAV, HBV, and HCV surveillance in France |
| Elisabeth Delarocque-Astagneau |
| Nov/2004 - Veyrier-du-Lac, France | | 237 Kb (.pdf) |
|
| Evaluation of viral hepatitis prevention and control measures-prospects: What still needs to be done in France |
| Jean-Claude Desenclos |
| Nov/2004 - Veyrier-du-Lac, France | | 98 Kb (.pdf) |
|
| Prediction of HCV-related morbidity and mortality burden in France |
| Sylvie Deuffic-Burban |
| Nov/2004 - Veyrier-du-Lac, France | | 194 Kb (.pdf) |
|
| Presentation of the VHPB meeting conclusions |
| Guido François |
| Nov/2004 - Veyrier-du-Lac, France | | 89 Kb (.pdf) |
|
| HBV immunisation policies in France |
| Nicole Guérin |
| Nov/2004 - Veyrier-du-Lac, France | | 159 Kb (.pdf) |
|
| French regional registries (HBV and HCV, Cote d'Or and Doubs) |
| Patrick Hillon |
| Nov/2004 - Veyrier-du-Lac, France | | 630 Kb (.pdf) |
|
| Surveillance of adverse events following immunisation in France |
| Alexis Jacquet |
| Nov/2004 - Veyrier-du-Lac, France | | 380 Kb (.pdf) |
|
| French national programme for viral hepatitis prevention and control |
| Anne-Marie Jullien-Depradeux |
| Nov/2004 - Veyrier-du-Lac, France | | 483 Kb (.pdf) |
|
| Prevention and residual risk of HCV, HIV, and HBV infection following blood transfusion |
| Syria Laperche |
| Nov/2004 - Veyrier-du-Lac, France | | 514 Kb (.pdf) |
|
| Organisation, preventive health-care system, and financement in France |
| Martine Le Quellec-Nathan |
| Nov/2004 - Veyrier-du-Lac, France | | 418 Kb (.pdf) |
|
| Impact of hepatitis B vaccine safety issues on vaccination strategies and their implementation in France |
| Daniel Levy-Bruhl |
| Nov/2004 - Veyrier-du-Lac, France | | 187 Kb (.pdf) |
|
| Injecting drug users and HCV infections in France: prevention strategies and results |
| Damien Lucidarme |
| Nov/2004 - Veyrier-du-Lac, France | | 493 Kb (.pdf) |
|
| French national programme for viral hepatitis prevention and control: preliminary results |
| Patrick Marcellin |
| Nov/2004 - Veyrier-du-Lac, France | | 139 Kb (.pdf) |
|
| Epidemiology of hepatitis A and E in France |
| Elisabeth Nicand |
| Nov/2004 - Veyrier-du-Lac, France | | 852 Kb (.pdf) |
|
| Research on viral hepatitis in France : organisation and funding |
| Jean-Michel Pawlotsky |
| Nov/2004 - Veyrier-du-Lac, France | | 676 Kb (.pdf) |
|
| Epidemiology of hepatitis C in France |
| Francoise Roudot-Thoraval |
| Nov/2004 - Veyrier-du-Lac, France | | 427 Kb (.pdf) |
|
| Preventive measures for prisoners in France |
| Claire Wartelle-Bladou |
| Nov/2004 - Veyrier-du-Lac, France | | 398 Kb (.pdf) |
|
| HBV and HCV infection in health-care workers in France |
| Yazdan Yazdanpanah |
| Nov/2004 - Veyrier-du-Lac, France | | 429 Kb (.pdf) |
|
| Epidemiology of hepatitis B in France |
| Fabien Zoulim |
| Nov/2004 - Veyrier-du-Lac, France | | 530 Kb (.pdf) |
|
| Vaccine supply in CEE and NIS |
| Katinka Aanjesen |
| May/2004 - Kyiv, Ukraine | | 949 Kb (.pdf) |
|
| Pre- and post vaccination testing and the issue of non-responders |
| Fransisco Averhoff |
| May/2004 - Kyiv, Ukraine | | 153 Kb (.pdf) |
|
| Introduction of a newborn hepatitis B immunisation programme in Turkey |
| Selim Badur, Ebru Usta |
| May/2004 - Kyiv, Ukraine | | 280 Kb (.pdf) |
|
| Current experience of hepatitis B vaccination in Italy |
| Paolo Bonanni |
| May/2004 - Kyiv, Ukraine | | 328 Kb (.pdf) |
|
| e-learning resource to strengthen financial planning of immunisation |
| Alan Brooks |
| May/2004 - Kyiv, Ukraine | | 494 Kb (.ppt) |
|
| Potential role of group procurement in the WHO European Region |
| Alan Brooks |
| May/2004 - Kyiv, Ukraine | | 261 Kb (.pdf) |
|
| Safety and quality of hepatitis B vaccines: Frequently asked questions in the WHO European Region |
| Philippe Duclos |
| May/2004 - Kyiv, Ukraine | | 514 Kb (.pdf) |
|
| Assessment of implementation of the hepatitis B prevention programme in Georgia |
| Lia Dzhabidze |
| May/2004 - Kyiv, Ukraine | | 165 Kb (.pdf) |
|
| Epidemiology of hepatitis B and vaccination programmes in the WHO European Region |
| Nedret Emiroglu |
| May/2004 - Kyiv, Ukraine | | 2,222 Kb (.pdf) |
|
| HBV, HCV, and HIV integrated programmes |
| Michael Favorov |
| May/2004 - Kyiv, Ukraine | | 857 Kb (.pdf) |
|
| Financial sustainability planning |
| Viktor Galyada |
| May/2004 - Kyiv, Ukraine | | 173 Kb (.pdf) |
|
| Overview of GAVI and the Vaccine Fund |
| Tore Godal |
| May/2004 - Kyiv, Ukraine | | 1,103 Kb (.pdf) |
|
| Overview of methods to evaluate the impact of hepatitis B immunisation programs |
| Susan Goldstein |
| May/2004 - Kyiv, Ukraine | | 353 Kb (.pdf) |
|
| Duration of protection after hepatitis B vaccination: current statut |
| Wolfgang Jilg |
| May/2004 - Kyiv, Ukraine | | 194 Kb (.pdf) |
|
| Blood safety in Central Asia Region |
| Aliya Jumagulova |
| May/2004 - Kyiv, Ukraine | | 664 Kb (.pdf) |
|
| Laboratory aspects of actute disease surveillance and the need for QA/QC |
| Tatiana Kalachnikova |
| May/2004 - Kyiv, Ukraine | | 370 Kb (.pdf) |
|
| Review of current recommendations regarding booster vaccination |
| Daniel Lavanchy |
| May/2004 - Kyiv, Ukraine | | 202 Kb (.pdf) |
|
| Strengthening immunisation systems and introduction of hepatitis B vaccine in CEE and NIS: meeting conclusions. |
| Alexandra Levitt |
| May/2004 - Kyiv, Ukraine | | 144 Kb (.pdf) |
|
| GAVI in the WHO European Region: results, current situation, and future |
| Andrei Lobanov |
| May/2004 - Kyiv, Ukraine | | 1,281 Kb (.pdf) |
|
| Burden of disease of Haemophilus influenzae type B in the WHO European Region |
| Andrei Lobanov |
| May/2004 - Kyiv, Ukraine | | 724 Kb (.pdf) |
|
| Injection safety of immunisation in the WHO European Region |
| Denis Maire |
| May/2004 - Kyiv, Ukraine | | 1,095 Kb (.pdf) |
|
| Vaccine procurement European perspectives |
| Denis Maire |
| May/2004 - Kyiv, Ukraine | | 198 Kb (.pdf) |
|
| Hepatitis C epidemiology in CEE and NIS countries |
| Harold Margolis |
| May/2004 - Kyiv, Ukraine | | 346 Kb (.pdf) |
|
| Acute viral hepatitis surveillance for hepatitis B vaccine evaluation program |
| Liudmila Mosin |
| May/2004 - Kyiv, Ukraine | | 163 Kb (.ppt) |
|
| Safe sharps waste collection and management in Samarkand, Uzbekistan |
| Irkin Musabaev |
| May/2004 - Kyiv, Ukraine | | 1,395 Kb (.pdf) |
|
| The importance of communication on immunisation safety |
| Dragoslav Popovic |
| May/2004 - Kyiv, Ukraine | | 499 Kb (.pdf) |
|
| Evaluation of hepatitis B prevention strategies in the Russian Federation |
| Marina Shevyreva |
| May/2004 - Kyiv, Ukraine | | 257 Kb (.pdf) |
|
| Implementation of financial sustainability planning in Kyrgyzstan |
| Ludmila Shteinke |
| May/2004 - Kyiv, Ukraine | | 290 Kb (.pdf) |
|
| Achievement with newborn and catch up hepatitis B immunisation programme in Kazakhstan |
| Tatiana Surdina |
| May/2004 - Kyiv, Ukraine | | 377 Kb (.pdf) |
|
| Financial sustainability planning of Uzbekistan |
| Dilorom Tursunova |
| May/2004 - Kyiv, Ukraine | | 216 Kb (.pdf) |
|
| Experience with sentinel surveillance in Kyrgyzstan |
| Rafik Usmanov |
| May/2004 - Kyiv, Ukraine | | 379 Kb (.pdf) |
|
| Birth dose: what is possible in view of other vaccines, combined vaccines, ... Reflections on schedules, dosage, vaccines and interchangeability of hepatitis B vaccines |
| Pierre Van Damme |
| May/2004 - Kyiv, Ukraine | | 224 Kb (.pdf) |
|
| Global epidemiology and prevention of hepatitis B |
| Steven Wiersma |
| May/2004 - Kyiv, Ukraine | | 717 Kb (.pdf) |
|
| WHO protocol for serologic surveillance |
| Steven Wiersma |
| May/2004 - Kyiv, Ukraine | | 103 Kb (.pdf) |
|
| Vaccine escape mutants of HBV |
| Ulus Akarca |
| Mar/2004 - Sevilla, Spain | | 2,487 Kb (.pdf) |
|
| The decline of hepatitis B virus infection in the Kingdom of Saudi Arabia |
| Banji Ayoola |
| Mar/2004 - Sevilla, Spain | | 489 Kb (.pdf) |
|
| Are booster immunisations needed for lifelong hepatitis B immunity? |
| Jangu Banatvala |
| Mar/2004 - Sevilla, Spain | | 236 Kb (.pdf) |
|
| Kinetics of hepatitis B surface antigen-specific immune responses in acute and chronic hepatitis B |
| Wulf Böcher |
| Mar/2004 - Sevilla, Spain | | 463 Kb (.pdf) |
|
| Follow-up of hepatitis B vaccination: studies in Spain |
| Vicente Carreño |
| Mar/2004 - Sevilla, Spain | | 990 Kb (.pdf) |
|
| Follow-up of hepatitis B vaccination in Canada |
| Bernard Duval |
| Mar/2004 - Sevilla, Spain | | 525 Kb (.pdf) |
|
| VHPB meeting conclusions on 'Hepatitis B vaccine: long-term efficacy, booster policy, and impact of HBV mutants on hepatitis B vaccination programmes' |
| David FitzSimons |
| Mar/2004 - Sevilla, Spain | | 138 Kb (.pdf) |
|
| Are booster doses of hepatitis B vaccine necessary? Current CDC recommendations and gaps in knowledge |
| Susan Goldstein |
| Mar/2004 - Sevilla, Spain | | 330 Kb (.pdf) |
|
| Follow-up of hepatitis B vaccination programmes in Gambia |
| Andy Hall |
| Mar/2004 - Sevilla, Spain | | 537 Kb (.pdf) |
|
| Immune memory after hepatitis B vaccination |
| Wolfgang Jilg |
| Mar/2004 - Sevilla, Spain | | 193 Kb (.pdf) |
|
| WHO booster recommendations |
| Daniel Lavanchy |
| Mar/2004 - Sevilla, Spain | | 158 Kb (.pdf) |
|
| Follow-up of hepatitis B vaccination programmes in Taiwan and Singapore |
| Sheng-Nan Lu |
| Mar/2004 - Sevilla, Spain | | 955 Kb |
|
| Hepatitis B vaccine studies in Alaska |
| Brian McMahon |
| Mar/2004 - Sevilla, Spain | | 732 Kb (.pdf) |
|
| Evaluation of the school-based hepatitis B vaccination programme in Catalonia (Spain) |
| Lluis Salleras |
| Mar/2004 - Sevilla, Spain | | 311 Kb (.pdf) |
|
| Follow-up of hepatitis B vaccination: studies in Thailand |
| Michel Stoffel |
| Mar/2004 - Sevilla, Spain | | 105 Kb (.pdf) |
|
| Update of the universal vaccination programme in Italy |
| Alessandro Zanetti |
| Mar/2004 - Sevilla, Spain | | 483 Kb (.pdf) |
|
| Epidemiology of hepatitis A in Germany |
| Katharina Alpers |
| Oct/2003 - Berlin, Germany | | 262 Kb (.pdf) |
|
| Groups at risk for hepatitis B infection - who should be vaccinated |
| Ulrich Bienzle |
| Oct/2003 - Berlin, Germany | | 121 Kb (.pdf) |
|
| Hepatitis A and B outbreaks among intravenous drug users in the Nordic Countries |
| Hans Blystad |
| Oct/2003 - Berlin, Germany | | 134 Kb (.pdf) |
|
| Hepatitis B epidemiology, surveillance, and prevention strategies in the Nordic Countries |
| Hans Blystad |
| Oct/2003 - Berlin, Germany | | 146 Kb (.pdf) |
|
| Universal vaccination against hepatitis B in Germany – a paediatrician’s point of view |
| Uwe Busching |
| Oct/2003 - Berlin, Germany | | 101 Kb (.pdf) |
|
| Presentation of the VHPB meeting conclusions, including discussion |
| David Fitzsimons |
| Oct/2003 - Berlin, Germany | | 97 Kb (.pdf) |
|
| Molecular epidemiology of HBV mutants |
| Wolfram Gerlich |
| Oct/2003 - Berlin, Germany | | 2,234 Kb (.pdf) |
|
| Organisation of the health care system in Germany |
| Johannes Hallauer |
| Oct/2003 - Berlin, Germany | | 416 Kb (.pdf) |
|
| Screening pregnant women for hepatitis B: results from two studies |
| Wolfgang Jilg |
| Oct/2003 - Berlin, Germany | | 88 Kb (.pdf) |
|
| Development of hepatitis B prevention in Germany - the first 10 years |
| Wolfgang Jilg |
| Oct/2003 - Berlin, Germany | | 82 Kb (.pdf) |
|
| Critical review of programme progress |
| Michael Kramer, Johannes Hallauer |
| Oct/2003 - Berlin, Germany | | 62 Kb (.pdf) |
|
| Federal law on communicable diseases (Infektionsschutzgesetz) - Reporting systems |
| Michael Kramer |
| Oct/2003 - Berlin, Germany | | 258 Kb (.pdf) |
|
| Evaluation of a hepatitis B selective vaccination programme in Norway |
| Hanne Nokleby |
| Oct/2003 - Berlin, Germany | | 78 Kb (.pdf) |
|
| School-entry monitoring of vaccination status |
| Gunter Pfaff |
| Oct/2003 - Berlin, Germany | | 399 Kb (.pdf) |
|
| Epidemiology of hepatitis B in Germany |
| Doris Radun |
| Oct/2003 - Berlin, Germany | | 244 Kb (.pdf) |
|
| Epidemiology of hepatitis A in Sweden - the same old story? |
| Lars Rombo |
| Oct/2003 - Berlin, Germany | | 298 Kb (.pdf) |
|
| Problems associated with the introduction of HBsAg-positive children in day care centres |
| Johan Struwe |
| Oct/2003 - Berlin, Germany | | 72 Kb (.pdf) |
|
| Investigation of a cluster of nosocomial HBV infections in Sweden - obstacles and efforts |
| Johan Struwe |
| Oct/2003 - Berlin, Germany | | 331 Kb (.pdf) |
|
| Countering the anti-vaccination movement and vaccination scares - Working with the media |
| Robert Aston |
| Mar/2003 - Geneva, Switzerland | | 4,286 Kb (.ppt) |
|
| Communication: The role of the industry |
| Hugues Bogaerts, Luc Hessel |
| Mar/2003 - Geneva, Switzerland | | 61 Kb (.ppt) |
|
| The Brighton Collaboration: comparability of vaccine safety data |
| Jan Bonhoeffer |
| Mar/2003 - Geneva, Switzerland | | 419 Kb (.ppt) |
|
| Impact of safety issues in Scotland |
| Claire Bramley |
| Mar/2003 - Geneva, Switzerland | | 1,386 Kb (.ppt) |
|
| The global advisory committee on Vaccine Safety (GACVS) and its communication strategy |
| Philippe Duclos |
| Mar/2003 - Geneva, Switzerland | | 214 Kb (.ppt) |
|
| Impact of safety issues in France |
| Nicole Guérin |
| Mar/2003 - Geneva, Switzerland | | 87 Kb (.ppt) |
|
| Impact of safety issues in Germany |
| Johannes Hallauer |
| Mar/2003 - Geneva, Switzerland | | 644 Kb (.ppt) |
|
| International impact of vaccine safety concerns |
| Mark Kane |
| Mar/2003 - Geneva, Switzerland | | 33 Kb (.ppt) |
|
| New communication issues around immunisation |
| Heidi Larson |
| Mar/2003 - Geneva, Switzerland | | 1,090 Kb (.ppt) |
|
| Thiomersal-related changes in vaccination recommendations and hepatitis B vaccine coverage among United States children |
| Harold Margolis |
| Mar/2003 - Geneva, Switzerland | | 350 Kb (.ppt) |
|
| Infant hepatitis B vaccination and childhood leukaemia |
| Harold Margolis |
| Mar/2003 - Geneva, Switzerland | | 87 Kb (.ppt) |
|
| Impact of litigation issues on hepatitis B vaccination |
| Robert Pless |
| Mar/2003 - Geneva, Switzerland | | 2,513 Kb (.pdf) |
|
| Impact of safety issues in Israel |
| Daniel Shouval |
| Mar/2003 - Geneva, Switzerland | | 96 Kb (.ppt) |
|
| The Immunization Action Coalition (IAC) |
| Deborah L. Wexler |
| Mar/2003 - Geneva, Switzerland | | 2,409 Kb (.ppt) |
|
| The Viral Hepatitis Prevention Board, 10 years of support to the control and prevention of viral hepatitis in Europe. |
| Alex Vorsters |
| Jan/2003 - San Antonio, Texas, USA | | 652 Kb (.ppt) |
|
| Molecular tracing of HCV: options for control of hospital transmission |
| Filippo Ansaldi |
| Nov/2002 - Catania, Italy | | 177 Kb (.ppt) |
|
| Prevention of hepatitis A during outbreaks and post exposure |
| Paolo Bonanni |
| Nov/2002 - Catania, Italy | | 275 Kb (.ppt) |
|
| Epidemiology of hepatitis B core/pre-core mutants in Italy |
| Maurizia Brunetto |
| Nov/2002 - Catania, Italy | | 1,430 Kb (.ppt) |
|
| Epidemiology of hepatitis A and E in Italy |
| Rosa Cristina Coppola |
| Nov/2002 - Catania, Italy | | 1,921 Kb (.ppt) |
|
| Epidemiology of hepatitis B and C in Italy from the eighties until now |
| Pietro Crovari |
| Nov/2002 - Catania, Italy | | 272 Kb (.ppt) |
|
| Update on WHO GAVI European Regional Working Group and hepatitis B immunization |
| Nedret Emiroglu |
| Nov/2002 - Catania, Italy | | 970 Kb (.ppt) |
|
| Presentation of the VHPB meeting conclusions |
| David FitzSimons |
| Nov/2002 - Catania, Italy | | 50 Kb (.ppt) |
|
| The new Italian guidelines for the use of hepatitis A vaccine |
| Elisabetta Franco |
| Nov/2002 - Catania, Italy | | 121 Kb (.ppt) |
|
| The hepatitis A epidemic in Puglia, Italy: lessons learnt and application of prevention programmes |
| Pier Luigi Lopalco |
| Nov/2002 - Catania, Italy | | 1,337 Kb (.ppt) |
|
| Integrated epidemiological system for acute viral hepatitis (SEIEVA) |
| Alfonso Mele |
| Nov/2002 - Catania, Italy | | 599 Kb (.ppt) |
|
| Organisation of the health care system in Italy |
| Maria Grazia Pompa |
| Nov/2002 - Catania, Italy | | 230 Kb (.ppt) |
|
| Programme of HBV vaccination targeted to risk groups - Long-term protection after hepatitis B vaccination in a cohort of exposed newborns |
| Tommaso Stroffolini |
| Nov/2002 - catania, Italy | | 49 Kb (.ppt) |
|
| Evaluation framework of viral hepatitis prevention programmes: examples in Italy - Impact of ten years of universal hepatitis B vaccination programmes |
| Tommaso Stroffolini |
| Nov/2002 - Catania, Italy | | 99 Kb (.ppt) |
|
| Prevention of hepatitis C and residual risk of HCV, HIV, and HBV infection following blood transfusion: results of an Italian study |
| Alessandro Zanetti |
| Nov/2002 - Catania, Italy | | 82 Kb (.ppt) |
|
| Hepatitis E in Italy |
| Alessandro Zanetti |
| Nov/2002 - Catania, Italy | | 158 Kb (.ppt) |
|
| Epidemiology of hepatitis B surface antigen mutants in Italy: role and consequences for vaccination programmes |
| Alessandro Zanetti |
| Nov/2002 - Catania, Italy | | 779 Kb (.ppt) |
|
| How to collect and evaluate surveillance and epidemiologic data for hepatitis C |
| Miriam Alter |
| May/2002 - Geneva, Switzerland | | 499 Kb (.ppt) |
|
| Hepatitis C infection in Turkey |
| Selim Badur |
| May/2002 - Geneva, Switzerland | | 393 Kb (.ppt) |
|
| Surveillance of hepatitis C infection in France |
| Jean-Claude Desenclos |
| May/2002 - Geneva, Switzerland | | 211 Kb (.ppt) |
|
| The hepatitis C virus |
| Peter Grob |
| May/2002 - Geneva, Switzerland | | 942 Kb (.pdf) |
|
| Estimating the global burden of HCV infections associated with unsafe health care injections |
| Yvan Hutin |
| May/2002 - Geneva, Switzerland | | 408 Kb (.ppt) |
|
| Global epidemiology of HCV infection |
| Daniel Lavanchy |
| May/2002 - Geneva, Switzerland | | 1,065 Kb (.pdf) |
|
| Natural history of HCV infection |
| Daniel Lavanchy |
| May/2002 - Geneva, Switzerland | | 1,092 Kb (.pdf) |
|
| Human immune response to hepatitis C virus |
| Geert Leroux-Roels |
| May/2002 - Geneva, Switzerland | | 893 Kb (.ppt) |
|
| Hepatitis C: therapeutic options |
| Michael Manns |
| May/2002 - Geneva, Switzerland | | 1,781 Kb (.ppt) |
|
| Prevention of hepatitis C virus infection: achievement through integration into established prevention programmes |
| Harold Margolis |
| May/2002 - Geneva, Switzerland | | 360 Kb (.ppt) |
|
| Epidemiology, prevention, and control programmes of hepatitis C in Egypt |
| Mostafa Mohamed |
| May/2002 - Geneva, Switzerland | | 901 Kb (.ppt) |
|
| Tackling the HCV epidemic in Switzerland |
| Francesco Negro |
| May/2002 - Geneva, Switzerland | | 336 Kb (.ppt) |
|
| Integrating prevention, control, and therapy for viral hepatitis: the Canadian model |
| David Patrick |
| May/2002 - Geneva, Switzerland | | 1,317 Kb (.ppt) |
|
| Laboratory and clinical diagnosis of HCV infection |
| Jean-Michel Pawlotsky |
| May/2002 - Geneva, Switzerland | | 210 Kb (.pdf) |
|
| Clinical manifestations of HCV infection |
| Daniel Shouval |
| May/2002 - Geneva, Switzerland | | 396 Kb (.ppt) |
|
| Health strategy on HCV in The Netherlands |
| Jan Van Hattum |
| May/2002 - Geneva, Switzerland | | 423 Kb (.ppt) |
|
| HCV injecting drug users: developing indicators of prevalence and responses |
| Lucas Wiessing |
| May/2002 - Geneva, Switzerland | | 1,299 Kb (.ppt) |
|
| Public health challenges for controlling HCV infection |
| Alessandro Zanetti |
| May/2002 - Geneva, Switzerland | | 107 Kb (.ppt) |
|
| Evaluation framework of viral hepatitis prevention programmes: examples in Italy - Impact of ten years of universal hepatitis B vaccination programmes |
| Paolo Bonanni |
| Jan/2002 - Catania, Italy | | 418 Kb (.ppt) |
|
| Combined paediatric vaccines for national immunisation programmes. |
| Francis André |
| Oct/2001 - St. Julians, Malta | | 1,631 Kb (.ppt) |
|
| Economic aspects of combined vaccines. |
| Philippe Beutels |
| Oct/2001 - St. Julians, Malta | | 59 Kb (.ppt) |
|
| Influence of combined vaccines on infant immunisation coverage – Recent data from Italy [Factors influencing vaccine uptake in Italy], Germany [Germany: recommendations and delivery of vaccines], and Belgium [Analysis of factors influencing vaccine uptake |
| Paolo Bonanni |
| Oct/2001 - St. Julians, Malta | | 1,098 Kb (.ppt) |
|
| Combined vaccines with a hepatitis B component - The role of non-clinical testing in ensuring their safety and efficacy. |
| Roland Dobbelaer |
| Oct/2001 - St. Julians, Malta | | 360 Kb (.ppt) |
|
| Presentation of the VHPB conclusions. |
| David FitzSimons |
| Oct/2001 - St. Julians, Malta | | 46 Kb (.ppt) |
|
| Infant and adolescent vaccination schedules in Europe |
| Nicole Guérin |
| Oct/2001 - St. Julians, Malta | | 86 Kb (.ppt) |
|
| Decision-making process and impact of implementation of hexavalent vaccines in national immunisation programmes: the case of Germany. |
| Wolfgang Jilg |
| Oct/2001 - St. Julians, Malta | | 62 Kb (.ppt) |
|
| Immunogenicity profile of combined vaccines in infants. |
| Helena Kayhty |
| Oct/2001 - St. Julians, Malta | | 508 Kb (.ppt) |
|
| Hepatitis B vaccination: an alternative (re)view. |
| Geert Leroux-Roels |
| Oct/2001 - St. Julians, Malta | | 984 Kb (.ppt) |
|
| New vaccine supply and financing: a case study of combination vaccines in developing countries. |
| Susan McKinney |
| Oct/2001 - St. Julians, Malta | | 417 Kb (.ppt) |
|
| Overview of the vaccination programme in Malta. |
| Mark Muscat |
| Oct/2001 - St. Julians, Malta | | 125 Kb (.ppt) |
|
| European regulatory authorities' perspective and view on proving safety and immunogenicity of combined vaccines - General aspects - Recent experiences. |
| Michael Pfleiderer |
| Oct/2001 - St. Julians, Malta | | 61 Kb (.ppt) |
|
| Infant and adolescent hepatitis B vaccination and use of combination vaccines - USA. |
| Fred Shaw |
| Oct/2001 - St. Julians, Malta | | 229 Kb (.ppt) |
|
| HEXAVAC - A new liquid DTacP-IPV-Hib-HB hexavalent vaccine - Overview of its clinical profile. |
| Benoit Soubeyrand |
| Oct/2001 - St. Julians, Malta | | 286 Kb (.ppt) |
|
| Importance of combined hepatitis B vaccines - Point of view of a paediatrician |
| Vytautas Usonis |
| Oct/2001 - St. Julians, Malta | | 187 Kb (.ppt) |
|
| Countries in Europe where combined vaccines are licensed. |
| Pierre Van Damme |
| Oct/2001 - St. Julians, Malta | | 27 Kb (.ppt) |
|
| Lessons learned from Turkey |
| Selim Badur |
| Jun/2001 - St. Petersburg, Russia | | 235 Kb (.ppt) |
|
| Financing Multi-Year Plans |
| Alan Brooks |
| Jun/2001 - St. Petersburg, Russia | | 108 Kb (.ppt) |
|
| Vaccine Fund |
| Alan Brooks |
| Jun/2001 - St. Petersburg, Russia | | 295 Kb (.ppt) |
|
| Hepatitis B vaccines: safety and side-effect profile. |
| Philippe Duclos |
| Jun/2001 - St. Petersburg, Russia | | 171 Kb (.ppt) |
|
| Review of the hepatitis B vaccination programmes and the progress made since Siofok, 1996 in CEE and NIS countries. |
| Nedret Emiroglu |
| Jun/2001 - St. Petersburg, Russia | | 526 Kb (.ppt) |
|
| In Country Coordination |
| Nedret Emiroglu |
| Jun/2001 - St. Petersburg, Russia | | 177 Kb (.ppt) |
|
| Overview of the hepatitis B, C and D epidemiology in CEE and NIS countries |
| Michael Favorov |
| Jun/2001 - St. Petersburg, Russia | | 132 Kb (.ppt) |
|
| Hepatitis B vaccines: quality, immunogenicity. |
| Susan Goldstein |
| Jun/2001 - St. Petersburg, Russia | | 144 Kb (.ppt) |
|
| Outcome evaluation and impact assessment. |
| Susan Goldstein |
| Jun/2001 - St. Petersburg, Russia | | 447 Kb (.ppt) |
|
| Details on long-term immunogenicity and Booster policy |
| Susan Goldstein |
| Jun/2001 - St. Petersburg, Russia | | 90 Kb (.ppt) |
|
| Outcome evaluation of an universal hepatitis B immuniszation programme |
| Johannes Hallauer |
| Jun/2001 - St. Petersburg, Russia | | 140 Kb (.ppt) |
|
| Hepatitis B vaccines: Quality issues, dosages, schedules |
| Wolfgang Jilg |
| Jun/2001 - St. Petersburg, Russia | | 97 Kb (.ppt) |
|
| Infectious Diseases Laboratory Quality Control – Essential Component for Public Health Improvement |
| Tatiana Kalachnikova |
| Jun/2001 - St. Petersburg, Russia | | 540 Kb (.ppt) |
|
| Overview of GAVI and the Global Fund for Children’s Vaccines |
| Mark Kane |
| Jun/2001 - St. Petersburg, Russia | | 729 Kb (.ppt) |
|
| GAVI Regional Working Group & Status of GAVI Implementation |
| Denis Maire |
| Jun/2001 - St. Petersburg, Russia | | 157 Kb (.ppt) |
|
| Hepatitis B prevention strategies in the broader context of hepatitis B and C prevention. |
| Harold Margolis |
| Jun/2001 - St. Petersburg, Russia | | 584 Kb (.ppt) |
|
| Global epidemiology of hepatitis B and review of prevention strategies in the world. |
| Eric Mast |
| Jun/2001 - St. Petersburg, Russia | | 722 Kb (.ppt) |
|
| Health Information Systems |
| Ljudmyla Muharska, Galina Shevschenko |
| Jun/2001 - St. Petersburg, Russia | | 463 Kb (.ppt) |
|
| Health Information Systems |
| Ljudmyla Muharska, Galina Shevschenko |
| Jun/2001 - St. Petersburg, Russia | | 504 Kb (.ppt) |
|
| Quality Control Systems for hepatitis B and C diagnostics in Uzbekistan. |
| Irkin Musabaev |
| Jun/2001 - St. Petersburg, Russia | | 337 Kb (.ppt) |
|
| Introduction of New Vaccines (example of Hib). |
| Pem Namgyal |
| Jun/2001 - St. Petersburg, Russia | | 136 Kb (.ppt) |
|
